JANX vs. USLM
Compare and contrast key facts about Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: JANX or USLM.
Correlation
The correlation between JANX and USLM is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
JANX vs. USLM - Performance Comparison
Key characteristics
JANX:
-0.50
USLM:
1.29
JANX:
-0.49
USLM:
1.96
JANX:
0.95
USLM:
1.24
JANX:
-0.64
USLM:
1.23
JANX:
-1.20
USLM:
2.77
JANX:
34.46%
USLM:
20.34%
JANX:
82.28%
USLM:
43.62%
JANX:
-83.14%
USLM:
-77.09%
JANX:
-55.58%
USLM:
-42.26%
Fundamentals
JANX:
$1.75B
USLM:
$2.63B
JANX:
-$1.28
USLM:
$3.79
JANX:
165.74
USLM:
8.27
JANX:
1.72
USLM:
5.22
JANX:
$9.34M
USLM:
$246.03M
JANX:
$8.83M
USLM:
$113.30M
JANX:
-$77.16M
USLM:
$117.28M
Returns By Period
In the year-to-date period, JANX achieves a -44.55% return, which is significantly lower than USLM's -31.52% return.
JANX
-44.55%
-3.95%
-40.66%
-39.22%
N/A
N/A
USLM
-31.52%
-5.20%
-12.35%
54.33%
39.80%
22.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
JANX vs. USLM — Risk-Adjusted Performance Rank
JANX
USLM
JANX vs. USLM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
JANX vs. USLM - Dividend Comparison
JANX has not paid dividends to shareholders, while USLM's dividend yield for the trailing twelve months is around 0.23%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JANX Janux Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
USLM United States Lime & Minerals, Inc. | 0.23% | 0.15% | 0.35% | 0.57% | 0.50% | 0.56% | 6.52% | 0.76% | 0.70% | 0.66% | 0.91% | 0.69% |
Drawdowns
JANX vs. USLM - Drawdown Comparison
The maximum JANX drawdown since its inception was -83.14%, which is greater than USLM's maximum drawdown of -77.09%. Use the drawdown chart below to compare losses from any high point for JANX and USLM. For additional features, visit the drawdowns tool.
Volatility
JANX vs. USLM - Volatility Comparison
Janux Therapeutics, Inc. (JANX) has a higher volatility of 21.21% compared to United States Lime & Minerals, Inc. (USLM) at 14.55%. This indicates that JANX's price experiences larger fluctuations and is considered to be riskier than USLM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
JANX vs. USLM - Financials Comparison
This section allows you to compare key financial metrics between Janux Therapeutics, Inc. and United States Lime & Minerals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities